Related Experiment Videos
[Experiences with the 32P test in tumor diagnosis]
Summary
The phosphorus-32 (32P) test accurately diagnosed eye tumors in 95% of cases. However, potential dangers necessitate exploring safer, noninvasive diagnostic alternatives.
Area of Science:
- Ophthalmology
- Nuclear Medicine
- Oncology
Background:
- The phosphorus-32 (32P) test has been utilized for diagnosing intraocular tumors.
- Assessing the diagnostic accuracy and reliability of the 32P test is crucial for clinical decision-making.
Purpose of the Study:
- To evaluate the diagnostic performance of the 32P test in a series of intraocular tumor cases.
- To review existing literature on the reliability and methodologies of the 32P test.
- To highlight the risks associated with 32P testing and advocate for alternative methods.
Main Methods:
- Conducted 186 phosphorus-32 (32P) tests on patients with suspected intraocular tumors.
- Defined positive test results as radiation increases exceeding 30% compared to tumor-free areas.
- Histologically examined 95 eyes to confirm diagnoses and assess test accuracy.
Main Results:
- The 32P test demonstrated high accuracy, with 95% correct diagnoses.
- Achieved 90 correct positive and 1 correct negative result.
- Identified 2 false positive and 2 false negative results among the tested cases.
Conclusions:
- The 32P test offers significant diagnostic accuracy for intraocular tumors.
- Potential risks associated with 32P necessitate caution in its application.
- Development of noninvasive nuclear-medical diagnostic methods is recommended to improve patient safety.